Literature DB >> 29031852

Inhibition of Cdk5 rejuvenates inhibitory circuits and restores experience-dependent plasticity in adult visual cortex.

Yue Li1, Laijian Wang2, Xinxin Zhang1, Mengyao Huang2, Sitong Li1, Xinxing Wang1, Lin Chen1, Bin Jiang3, Yupeng Yang4.   

Abstract

Cyclin-dependent kinase 5 (Cdk5) acts as an essential modulator for neural development and neurological disorders. Here we show that Cdk5 plays a pivotal role in modulating GABAergic signaling and the maturation of visual system. In adult mouse primary visual cortex, Cdk5 formed complex with the GABA synthetic enzyme glutamate decarboxylase GAD67, but not with GAD65. In addition to enhancement in the surface level of NR2B-containing NMDA receptors, inhibition of Cdk5 reduced the protein levels of GADs and Otx2, while leaving intact the expression of vesicular GABA transporter and subunits of GABAA or AMPA receptors. Whole-cell patch-clamp recording in layer II/III pyramidal neurons revealed a decrease in the frequency of miniature inhibitory postsynaptic current (mIPSC). Consequently, pharmacological inhibition and genetic knockdown of Cdk5 in adult mice led to a restoration of juvenile-like ocular dominance plasticity in vivo and long-term synaptic potential in layer II/III induced by white matter stimulation in vitro. Interestingly, we did not observe an alteration of perineuronal nets of extracellular matrix, but a reinstatement of the capability to evoke long-term depression at inhibitory synapses (iLTD), which depended on presynaptic endocannabinoid receptors and was a sign of the rejuvenated GABAergic synapses. Enhancement of GABA signaling by diazepam impeded ocular dominance plasticity rescued by Cdk5 inhibition. These results thus suggest that a physiological role of Cdk5 in visual cortex is to consolidate and stabilize neural circuits through controlling GABAergic signaling.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adult plasticity; Cdk5; Cortical circuits; GABAergic inhibition; LTP; iLTD

Mesh:

Substances:

Year:  2017        PMID: 29031852     DOI: 10.1016/j.neuropharm.2017.10.015

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  6 in total

1.  Closing the Critical Period Is Required for the Maturation of Binocular Integration in Mouse Primary Visual Cortex.

Authors:  Jiangping Chan; Xiangwen Hao; Qiong Liu; Jianhua Cang; Yu Gu
Journal:  Front Cell Neurosci       Date:  2021-11-26       Impact factor: 5.505

2.  Phosphorylation of CRMP2 by Cdk5 Negatively Regulates the Surface Delivery and Synaptic Function of AMPA Receptors.

Authors:  Longfei Cheng; Keen Chen; Jiong Li; Jiaming Wu; Jiaqi Zhang; Li Chen; Guoqing Guo; Jifeng Zhang
Journal:  Mol Neurobiol       Date:  2021-11-12       Impact factor: 5.682

3.  Systemic Administration of a Brain Permeable Cdk5 Inhibitor Alters Neurobehavior.

Authors:  Alan Umfress; Sarbjit Singh; Kevin J Ryan; Ayanabha Chakraborti; Florian Plattner; Yogesh Sonawane; Jayapal Reddy Mallareddy; Edward P Acosta; Amarnath Natarajan; James A Bibb
Journal:  Front Pharmacol       Date:  2022-05-12       Impact factor: 5.988

4.  Computational Simulations Identified Two Candidate Inhibitors of Cdk5/p25 to Abrogate Tau-associated Neurological Disorders.

Authors:  Amir Zeb; Minky Son; Sanghwa Yoon; Ju Hyun Kim; Seok Ju Park; Keun Woo Lee
Journal:  Comput Struct Biotechnol J       Date:  2019-04-22       Impact factor: 7.271

5.  A sex-dependent delayed maturation of visual plasticity induced by adverse experiences in early childhood.

Authors:  Yueqin Liu; Zhenni Wang; Xinxin Zhang; Sitong Li; Wei Wu; Xin Li; Yupeng Yang
Journal:  Neurobiol Stress       Date:  2020-10-14

6.  Inhibition of Cdk5 in PV Neurons Reactivates Experience-Dependent Plasticity in Adult Visual Cortex.

Authors:  Xinxin Zhang; Huiping Tang; Sitong Li; Yueqin Liu; Wei Wu; Yue Li; Chenchen Ma; Xiao Ma; Lin Chen; Yupeng Yang
Journal:  Int J Mol Sci       Date:  2021-12-24       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.